11 Stocks Under $25 To Buy Now
In this piece, we will take a look at the 11 stocks under $25 to buy now.
Veradigm Inc. (MDRX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Silver Point Capital Edward A. Mule | 3,861,000 | $29,729,700 | 1.75% | |
| 2. | Tyro Capital Management Dan Mcmurtrie | 1,176,015 | $9,055,315 | 5.23% | |
| 3. | One Fin Capital David Macknight | 980,000 | $7,546,000 | 2.57% | |
| 4. | Mason Capital Management Kenneth Mario Garschina | 938,238 | $7,224,433 | 0.99% | |
| 5. | Becker Drapkin Management Matthew Drapkin And Steven R. Becker | 450,000 | $3,465,000 | 1.24% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.00 | 2,398,725 | Large Shareholder | 11,435,151 | 2024-03-01 | Filing | |
| $6.00 | 1,599,150 | Large Shareholder | 9,612,586 | 2024-03-01 | Filing | |
| $6.09 | 278,250 | Large Shareholder | 9,036,426 | 2024-02-29 | Filing | |
| $6.09 | 246,750 | Large Shareholder | 8,013,436 | 2024-02-29 | Filing | |
| $6.81 | 3,021,000 | Large Shareholder | 8,758,176 | 2024-02-28 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.33 | 10,000 | Officer, Director | 669,017 | 2023-02-16 | Filing | |
| $17.38 | 10,000 | Officer, Director | 679,017 | 2023-02-15 | Filing | |
| $18.42 | 8,642 | Officer | 222,604 | 2022-12-12 | Filing | |
| $18.47 | 43,134 | Director | 32,384 | 2022-12-06 | Filing | |
| $18.06 | 10,000 | Officer, Director | 689,017 | 2022-11-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 18,880,525 | $198,056,707 | 0% | |
| 2. | 14,275,875 | $149,753,929 | 0% | |
| 3. | 8,977,589 | $94,174,892 | 0.02% | |
| 4. | 5,806,297 | $60,908,056 | 0.01% | |
| 5. | 46,562,000 | $47,222,333 | 0.84% |
News See All
Ken Fisher Portfolio: 15 Biggest Small-Cap Positions
In this article, we will discuss Ken Fisher portfolio: 15 biggest small-cap positions.
5 Cash-Rich Small Cap Stocks To Invest In
Needham analyst Ami Fadia initiated coverage of Cogent Biosciences with a Buy rating and $24 price target on December 14.
Ken Fisher Super Stocks: 5 Biggest Small-Cap Stocks
In this article, we discuss the 5 biggest small-cap stocks in the Ken Fisher portfolio.
5 Small Cap Stocks That Are Too Cheap To Ignore
In this piece, we will take a look at the five small cap stocks that are too cheap to ignore.
5 Small Company Stocks You Should Own Now for the Next Decade
In this article, we discuss 5 small company stocks you should own now for the next decade.
5 Small-Cap Stocks to Buy According to Ken Fisher
In this article, we discuss 5 small-cap stocks to buy according to Ken Fisher.
Is Allscripts Healthcare Solutions Inc (MDRX) A Good Stock To Buy?
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September.
Is Allscripts Healthcare Solutions Inc (MDRX) Going to Burn These Hedge Funds?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Hedge Fund and Insider Trading News: Steve Cohen, Bill Miller, Michael Burry, John Paulson, Elliott Management, Sancus Capital Management, Oaktree Capital Management LP, Allscripts Healthcare Solutions Inc (MDRX), and More
Steve Cohen vented his frustration with the New York Mets Wednesday after his team lost to the San Francisco Giants, asking how professional hitters could be “this unproductive.” The Mets are now ...
Billionaire Hedge Funds
